ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998

Pennsylvania Issues RFPs For Cancer Control Program

October 21, 1983

In Brief: Harkin Proposes To Add Another $400 Million To NCU Budget, Money To Come Forom Defense

July 26, 1991